Before Scott Rocklage joined SAM Ventures Management, he made one of the biggest mistakes in his life.
On December 31st 2001, the last night of that year, he was going home from the airport in a limousine At that time, he was the CEO of Cubist Pharmaceuticalss Inc. and had just learned that their most important product had failed a clinical test.
He told his wife what had happened and made her swear that she would not tell anyone because it would be considered insider trading. She told somebody anyway and Rockludge never made the same mistake again.
This story is just small part of Rocklage’s life.
By the time that Rocklage had joined SAM in 2003, he already had 30 years of experience in the healthcare management business.
He helped get FDA approval for Cubicin, Teslascan and Omniscan.
He worked at EntreMed as Executive Chairman, at Cubist Pharmaceuticals, at Catalytica as a Research and Development person, at Relypsa as an Executive Chairman and at Nycomed Salutar, as a President and CEO. Read more: Scott Racklage | Bloomberg and Scott Rocklage | LinkedIn
Scott did have the education to prepare him for his future in the health management industry. He got Bachelor’s of Science in Chemistry from University of California at Berkeley and a doctorate in Chemistry from MIT. At MIT, he was lucky enough to work with Richard Schrack, a Nobel Prize winner in chemistry.
He is either the inventor or co-inventor of about 30 US parents and has been published about 100 times, all peer reviewed.
At SAM Ventures, Rocklage has been successful and has certainly overcome any mistakes that he made before joining this company.